• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The double burden of disease of COVID-19 in cardiovascular patients: overlapping conditions could lead to overlapping treatments.

作者信息

Gonzalez-Jaramillo Nathalia, Low Nicola, Franco Oscar H

机构信息

1Institute of Social and Preventive Medicine, University of Bern, Mittelstrasse 43, 3012 Bern, Switzerland.

2Graduate School of Health Sciences, University of Bern, Bern, Switzerland.

出版信息

Eur J Epidemiol. 2020 Apr;35(4):335-337. doi: 10.1007/s10654-020-00628-1. Epub 2020 Apr 15.

DOI:10.1007/s10654-020-00628-1
PMID:32296994
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7158753/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/415c/7192857/2b9dad8102a5/10654_2020_628_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/415c/7192857/2b9dad8102a5/10654_2020_628_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/415c/7192857/2b9dad8102a5/10654_2020_628_Fig1_HTML.jpg

相似文献

1
The double burden of disease of COVID-19 in cardiovascular patients: overlapping conditions could lead to overlapping treatments.心血管疾病患者中新冠病毒病的双重疾病负担：重叠病症可能导致重叠治疗。
Eur J Epidemiol. 2020 Apr;35(4):335-337. doi: 10.1007/s10654-020-00628-1. Epub 2020 Apr 15.
2
SCAI initiatives during the COVID-19 pandemic.新冠疫情期间的SCAI倡议。
Catheter Cardiovasc Interv. 2020 Nov;96(5):995-996. doi: 10.1002/ccd.29058. Epub 2020 Jun 20.
3
COVID-19: how things change in a short while.新冠疫情：世事瞬息万变。
Eur Heart J Cardiovasc Pharmacother. 2020 Sep 1;6(5):280-281. doi: 10.1093/ehjcvp/pvaa092.
4
Cardiovascular CT in a world adrift.漂浮世界中的心血管CT
J Cardiovasc Comput Tomogr. 2020 Sep-Oct;14(5):381. doi: 10.1016/j.jcct.2020.08.002. Epub 2020 Aug 6.
5
A close-up on COVID-19 and cardiovascular diseases.聚焦 COVID-19 与心血管疾病。
Nutr Metab Cardiovasc Dis. 2020 Jun 25;30(7):1057-1060. doi: 10.1016/j.numecd.2020.04.001. Epub 2020 Apr 8.
6
Crucial Conversations With Patients in the Era of COVID-19.COVID-19时代与患者的关键对话
Circulation. 2020 Jul 21;142(3):191-193. doi: 10.1161/CIRCULATIONAHA.120.047374. Epub 2020 May 6.
7
Coronavirus disease 2019 and cardiovascular implications.新型冠状病毒病 2019 与心血管影响。
J Cardiovasc Med (Hagerstown). 2020 Oct;21(10):725-732. doi: 10.2459/JCM.0000000000001068.
8
COVID-19 and the Cardiovascular System.新型冠状病毒肺炎与心血管系统
Crit Care Nurs Q. 2020 Oct/Dec;43(4):381-389. doi: 10.1097/CNQ.0000000000000323.
9
The Landscape of Cardiovascular Clinical Trials in the United States Initiated Before and During COVID-19.美国在新冠疫情之前及期间启动的心血管临床试验概况
J Am Heart Assoc. 2020 Sep 15;9(18):e018274. doi: 10.1161/JAHA.120.018274. Epub 2020 Jul 27.
10
Rapid Scholarly Dissemination and Cardiovascular Community Engagement to Combat the Infodemic of the COVID-19 Pandemic.快速学术传播与心血管领域社区参与以应对新冠疫情的信息疫情
Can J Cardiol. 2020 Jun;36(6):969.e1-969.e2. doi: 10.1016/j.cjca.2020.03.042. Epub 2020 Apr 4.

引用本文的文献

1
COVID-19 and Acute Cardiac Injury: Clinical Manifestations, Biomarkers, Mechanisms, Diagnosis, and Treatment.COVID-19 与急性心脏损伤：临床表现、生物标志物、发病机制、诊断与治疗。
Curr Cardiol Rep. 2023 Aug;25(8):817-829. doi: 10.1007/s11886-023-01902-w. Epub 2023 Jun 14.
2
A mixed method approach to understanding the impact of COVID-19 on patients with or at risk for aortic dissection.一种混合方法，用于了解 COVID-19 对主动脉夹层或有风险的患者的影响。
Semin Vasc Surg. 2022 Mar;35(1):100-109. doi: 10.1053/j.semvascsurg.2022.02.006. Epub 2022 Feb 23.
3
Inflammatory and Hypercoagulable Biomarkers and Clinical Outcomes in COVID-19 Patients.

本文引用的文献

1
Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: A modeling study in Hubei, China, and six regions in Europe.估算疫情早期 SARS-CoV-2 的死亡率：在中国湖北和欧洲六个地区的建模研究。
PLoS Med. 2020 Jul 28;17(7):e1003189. doi: 10.1371/journal.pmed.1003189. eCollection 2020 Jul.
2
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.新冠病毒病患者中的肾素-血管紧张素-醛固酮系统抑制剂
N Engl J Med. 2020 Apr 23;382(17):1653-1659. doi: 10.1056/NEJMsr2005760. Epub 2020 Mar 30.
3
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
新冠病毒感染患者的炎症和高凝生物标志物与临床结局
J Clin Med. 2021 Jul 13;10(14):3086. doi: 10.3390/jcm10143086.
4
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection.严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）：一种全身性感染。
Clin Microbiol Rev. 2021 Jan 13;34(2). doi: 10.1128/CMR.00133-20. Print 2021 Mar 17.
5
Prevalence and risk factors of disability and anxiety in a retrospective cohort of 432 survivors of Coronavirus Disease-2019 (Covid-19) from China.中国一项回顾性队列研究的 432 例新型冠状病毒病（COVID-19）幸存者的残疾和焦虑患病率及其危险因素。
PLoS One. 2020 Dec 17;15(12):e0243883. doi: 10.1371/journal.pone.0243883. eCollection 2020.
6
A pharmacological framework for integrating treating the host, drug repurposing and the damage response framework in COVID-19.在 COVID-19 中整合宿主治疗、药物重定位和损伤反应框架的药理学框架。
Br J Clin Pharmacol. 2021 Mar;87(3):875-885. doi: 10.1111/bcp.14551. Epub 2020 Nov 18.
高血压和糖尿病患者感染新型冠状病毒肺炎（COVID-19）的风险会增加吗？
Lancet Respir Med. 2020 Apr;8(4):e21. doi: 10.1016/S2213-2600(20)30116-8. Epub 2020 Mar 11.
4
COVID-19 and the cardiovascular system.新型冠状病毒肺炎与心血管系统。
Nat Rev Cardiol. 2020 May;17(5):259-260. doi: 10.1038/s41569-020-0360-5.
5
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.中国武汉严重 COVID-19 患者的临床病程和结局：一项单中心、回顾性、观察性研究。
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.
6
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses.SARS-CoV-2 及其他 B 属β冠状病毒的细胞进入和受体使用功能评估。
Nat Microbiol. 2020 Apr;5(4):562-569. doi: 10.1038/s41564-020-0688-y. Epub 2020 Feb 24.
7
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征：描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
8
A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension.血管紧张素转化酶 2 在人类肺动脉高压中的潜在治疗作用。
Eur Respir J. 2018 Jun 21;51(6). doi: 10.1183/13993003.02638-2017. Print 2018 Jun.
9
A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome.一项重组人血管紧张素转换酶 2 在急性呼吸窘迫综合征中的临床试验。
Crit Care. 2017 Sep 7;21(1):234. doi: 10.1186/s13054-017-1823-x.
10
The ACE2-Ang (1-7)-Mas receptor axis attenuates cardiac remodeling and fibrosis in post-myocardial infarction.血管紧张素转换酶2-血管紧张素（1-7）-Mas受体轴可减轻心肌梗死后的心脏重塑和纤维化。
Mol Med Rep. 2017 Aug;16(2):1973-1981. doi: 10.3892/mmr.2017.6848. Epub 2017 Jun 23.